OriGene Logo

Customer Login

Checkout as a new customer

Creating an account has many benefits:

  • See order and shipping status
  • Track order history
  • Check out faster
Create an Account

TissueScan, Prostate Cancer cDNA Array I

Be the first to review this product
SKU
HPRT101
48 samples covering 7-normal, 7-Stage II, 3-III, 31-N/R. Available in 2, 5, 10 identical plates.
  $1,060.00
2 Weeks*

Frequently Bought Together (4)

D11-18 Polink-1 HRP Polymer Detection for MOUSE and RABBIT antibodies on human tissue
18 ml
$420.00
D12-6 Polink-1 HRP Polymer Detection for MOUSE antibody on human or animal tissue (non-rodent)
6 ml
$250.00
HP205798 qSTAR qPCR primer pairs against Homo sapiens gene GAPDH 200 reactions
$150.00
MP205604 qSTAR qPCR primer pairs against Mus musculus gene Gapdh 200 reactions
$150.00
Specifications
Specifications
Product Data
TissueScan Type Cancer Specific
Array Name Prostate Cancer cDNA Array I
Clinical Info
Diagnosis Category Prostate Cancer
Tissue Prostate
Shipping Ambient
Description 48 samples covering 7-normal, 7-Stage II, 3-III, 31-N/R. Available in 2, 5, 10 identical plates.
Reviews
Write Review
 
 
 
 
 

Be the first to review this product

Please note:
Only reviews with images are eligible for a $20/20€ Amazon gift card.
Reviews without images are eligible for a $10/10€ Amazon gift card.
For more details about the terms and conditions, please visit the promotion page.

Review image
Documents
Resources

file-alt Citations

DCUN1D1 Is an Essential Regulator of Prostate Cancer Proliferation and Tumour Growth That Acts through Neddylation of Cullin 1, 3, 4A and 5 and Deregulation of Wnt/Catenin Pathway
Vava, Paccez, Wang et al
Cells (2023) 12 (15) DOI: 10.3390/cells12151973
Cited by 15
AI Summary: OriGene's TissueScan Prostate Cancer Tissue Array I was used in this study to evaluate DCUN1D1 expression in human prostate cancer tissue samples by RT-PCR, helping to establish its upregulation in prostate cancer.
Snippet: QIAshredder (Qiagen, Valencia, CA, USA) and the RNeasy mini kit (Qiagen) for tissue samples or cells, as recommended by the manufacturer. For evaluation of DCUN1D1 expression in human tissue samples, OriGene TissueScan Prostate Cancer Tissue Array I (OriGene Technologies, Rockville, MD, USA) was analysed by RT-PCR following the manufacturer’s protocol. All samples were normalized against GAPDH
FigureFigureFigure
Anti-CCR4 treatment depletes regulatory T cells and leads to clinical activity in a canine model of advanced prostate cancer
Maeda, Motegi, Iio et al
J Immunother Cancer (2022) 10 (2) DOI: 10.1136/jitc-2021-003731
Cited by 51
AI Summary: OriGene Technologies contributed to the study by providing paraffin-embedded sections of prostate specimens from healthy volunteers and prostate cancer patients, which were used for immunohistochemical analyses.
Snippet: cancer and 14 healthy dogs (online supplemental table S1). Human samples We obtained paraffin-embedded sections of prostate specimens from 6 healthy volunteers and 11 patients with prostate cancer (OriGene Technologies). Characteristics of human patients with prostate cancer are summarized in online supplemental table S2. 10.1136/jitc-2021-003731.supp2 Supplementary data Immunohistochemistry;-...
FigureFigureFigure
DNA methylation association with stage progression of head and neck squamous cell carcinoma
Ghafarpour, Khansari, Banaei-Moghaddam et al
Comput Biol Med (2021) 134, 104473 DOI: 10.1016/j.compbiomed.2021.104473
Cited by 11
AI Summary: OriGene products, specifically the human breast and prostate cancer expression panels HCRT101 and HPRT101, were used to analyze COL6A6 gene expression as part of the study's investigation into epigenetic regulators associated with head and neck squamous cell carcinoma progression.
Snippet: COL6A6 is a gene related to Collagen VI, a ubiquitous extracellular matrix (ECM) protein, and is associated with cells' basement membranes. This gene is part of commercially available human breast and prostate cancer expression panels (HCRT101 and HPRT101;This gene is part of commercially available human breast and prostate cancer expression panels (HCRT101 and HPRT101, Origene)
The long non-coding RNA GHSROS reprograms prostate cancer cell lines toward a more aggressive phenotype
Thomas, Jeffery, Gahete et al
PeerJ (2021) 9, e10280 DOI: 10.7717/peerj.10280
Cited by 9
AI Summary: In this study, OriGene products, specifically the GHSROS expression plasmid (RC208374) and control vector (PS100001), were used to generate prostate cancer cell lines overexpressing GHSROS, enabling the authors to assess the functional role of this lncRNA in promoting aggressive cancer phenotypes.
FigureFigureFigure
Histone Demethylase KDM4C Stimulates the Proliferation of Prostate Cancer Cells via Activation of AKT and c-Myc
Lin, Wang, Chen et al
Cancers (Basel) (2019) 11 (11) DOI: 10.3390/cancers11111785
AI Summary: OriGene's TissueScan Prostate Tissue qPCR Array (HPRT501~503) was used in this study to measure KDM4C mRNA levels across human prostate tissues and cancer stages, enabling the authors to correlate KDM4C expression with prostate cancer progression.
Snippet: The KDM4C mRNA level of human prostate tissue and different stages of prostate cancer were determined on TissueScan Prostate Tissue qPCR Array HPRT501~503 (OriGene Technologies, Rockville, MD, USA) according to the manufacturer’s instruction with Maxima SYBR Green/ROX qPCR Master Mix (2×) (Fermentas, Glen Burnie, MA, USA) and analyzed by ABI PRISM 7000 (Applied Biosystems/Life Technologies, Carlsbad, CA, USA). …
Elevation of androgen receptor promotes prostate cancer metastasis by induction of epithelial-mesenchymal transition and reduction of KAT5
Lin, Jan, Kuo et al
Cancer Sci. (2018) 109 (11), 3564-3574 DOI: 10.1111/cas.13776
AI Summary: OriGene’s TissueScan Prostate Tissue qPCR Array (HPRT101~103) was used to measure KAT5 mRNA levels across different stages of prostate cancer, helping to elucidate the relationship between KAT5 expression and prostate cancer progression in this study.
Snippet: The KAT5 mRNA level of human prostate tissue and different stages of prostate cancer was determined on TissueScan Prostate Tissue qPCR Array HPRT101~103 (OriGene Technologies, Rockville, MD, USA) according to the manufacturer's instructions with Maxima SYBR Green/ROX qPCR Master Mix (2×) (Fermentas, Glen Burnie, MA, USA) and analyzed by Applied Biosystems 7500 Real‐Time PCR system (Thermo Scientific, Waltham, MA, USA). …
FigureFigureFigure
Showing 1-6 of 22 papers.
Powered by BizGenius
*Delivery time may vary from web posted schedule. Occasional delays may occur due to unforeseen complexities in the preparation of your product. International customers may expect an additional 1-2 weeks in shipping.

Related Products